Tata Memorial Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Tata Memorial Hospital takes part in 5 sessions at ESMO 2026 in Madrid. Its program centres on affordable cancer care, including cost-saving ways to use immune checkpoint inhibitors and adapting treatment standards at scale when resources are limited. It also covers treatment before surgery for HER2-positive early breast cancer.

OrganizationESMO 2026 Attendance
tmc.gov.in
Cancer centre & hospital
Cancer treatment and research hospital in Mumbai, India, run by Tata Memorial Centre, a government-aided cancer centre under the Department of Atomic Energy.
Talk
Fri Oct 23
17:15–17:35
Optimized approaches to checkpoint inhibitors
The exorbitant costs of cancer care: What can we do?
Abstract
Sun Oct 25
09:08–09:18
Talk
Sun Oct 25
10:35–10:55
Neoadjuvant therapy for HER2+ breast cancer
Optimising treatment for HER2+ early breast cancer
Breast cancer
Talk
Mon Oct 26
10:52–11:07
From evidence to access: Operationalising adaptation at scale
When standards are unsustainable: Redefining cancer treatment under resource pressure
Abstract
Mon Oct 26
14:45–14:50

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Tata Memorial Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction